title: Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
authors.affiliation: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Medical College, Ansan, Korea.
authors.forename: Hyung Joon
authors.initials: HJ
authors.lastname: Yim
mesh_terms: D000225:Adenine / Q000008:administration & dosage; D000998:Antiviral Agents / Q000008:administration & dosage; D004279:DNA, Viral; D006513:Hepatitis B e Antigens / Q000627:therapeutic use; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D063065:Organophosphonates / Q000008:administration & dosage; D000068698:Tenofovir; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D063065:Organophosphonates; D019259:Lamivudine; D000068698:Tenofovir; D000225:Adenine
keywords: Chronic hepatitis B; Resistance; Suboptimal; Tenofovir; Treatment failure